I saw this on Simpily Wall St yesterday (I know not the best place for comprehensive research but they seem to do a good job of bringing data together). Both valuation and earnings/revenue growth is based on data from 7 analysts reports. I'm assuming this doesn't include any revenue from COVID-19 ARDS.
Based on FY 2025 projected earnings of $709m and a market/industry P/E ratio of 19.2-53.7 that gives us a projected 2025 share price of $22.97-$64.23 (based on today's closing price of $5.24 / market cap of $3,106m).
Note that this excludes the potential for COVID-19 ARDS approval and presumably includes risked ratios for earnings of all unapproved products.
I saw this on Simpily Wall St yesterday (I know not the best...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $394.9K | 429.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 62539 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 81992 | 33 |
View Market Depth
| Last trade - 11.03am 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |